Correlation Between Hepion Pharmaceuticals and Axsome Therapeutics

Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Axsome Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Axsome Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Hepion Pharmaceuticals and Axsome Therapeutics, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Axsome Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Axsome Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Axsome Therapeutics.

Diversification Opportunities for Hepion Pharmaceuticals and Axsome Therapeutics

0.23

Correlation Coefficient

Hepion Pharmaceuticals  Axsome Therapeutics

Modest diversification

The 3 months correlation between Hepion and Axsome is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Axsome Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Axsome Therapeutics and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Axsome Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Axsome Therapeutics has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Axsome Therapeutics go up and down completely randomly.

Pair Corralation between Hepion Pharmaceuticals and Axsome Therapeutics

Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to generate 4.07 times less return on investment than Axsome Therapeutics. In addition to that, Hepion Pharmaceuticals is 1.19 times more volatile than Axsome Therapeutics. It trades about 0.04 of its total potential returns per unit of risk. Axsome Therapeutics is currently generating about 0.18 per unit of volatility. If you would invest  8,903  in Axsome Therapeutics on September 1, 2024 and sell it today you would earn a total of  919.00  from holding Axsome Therapeutics or generate 10.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Hepion Pharmaceuticals  vs.  Axsome Therapeutics

Hepion Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Hepion Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Hepion Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Axsome Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Axsome Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Axsome Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Hepion Pharmaceuticals and Axsome Therapeutics

The main advantage of trading using opposite Hepion Pharmaceuticals and Axsome Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Axsome Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axsome Therapeutics will offset losses from the drop in Axsome Therapeutics' long position.

The idea behind Hepion Pharmaceuticals and Axsome Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.